PYC.AX
PYC Therapeutics Limited
ASXAUDEQUITY
Healthcare
DELAYED
Last price
2.07
▼ 0.13 (5.91%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
2.19
Prev close
2.20
Day high
2.20
Day low
2.05
Volume
2.83M
Market cap
$2.04B
P/E (TTM)
—
52W range
0.85 – 2.23
Day trading desk
Gap from prior close
-0.45%
Prior close 2.20
VWAP
2.12
-2.49% from price
Relative volume
1.61×
Unusually busy
Session range
7.32%
2.05 – 2.20
Position in range
13%
Near session low
ATR (14D)
0.11
5.52% of price
Prior day high
2.22
PDH
Prior day low
2.15
PDL
Bid / ask spread
—
Quote not published
Session volume
2.81M
Avg 1.74M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-3.27%
-1.9%
1M
+23.58%
+19.9%
3M
+54.48%
+51.4%
6M
+38.00%
+26.9%
YTD
+25.08%
+12.8%
1Y
+59.23%
+39.2%
3Y
+261.15%
+187.0%
5Y
+44.46%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PYC.AX open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
192.32M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Mar 24, 26 | Hockings (Rohan) Other Executive |
BUY | 82.55K | $69.84K | Direct |
| Mar 6, 26 | Hockings (Rohan) Other Executive |
OTHER | 80.01K | $84.36K | Direct |
| Mar 6, 26 | Constable (Ian) Director (Non-Executive) |
OTHER | 123.00K | $129.69K | Direct |
| Nov 26, 25 | Hockings (Rohan) Other Executive |
BUY | 133.35K | $130.30K | Direct |
| Nov 18, 25 | Tribe (Alan William) Former |
— | 186.73M | — | Direct |
| Sep 22, 25 | Constable (Ian) Director (Non-Executive) |
— | 205.00K | — | Direct |
| Sep 21, 25 | Jefferey (Ian) Director (Non-Executive) |
— | 205.00K | — | Direct |
| Feb 27, 25 | Tribe (Alan William) Non Executive Chairman |
OTHER | 28.00M | $21.81M | Direct |
| Nov 26, 24 | Tribe (Alan William) Non Executive Chairman |
— | 1.43B | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Constable (Ian) |
Director (Non-Executive) | 328.00K | Other |
Hockings (Rohan) |
Other Executive | 295.91K | Purchase |
Jefferey (Ian) |
Director (Non-Executive) | 205.00K | Other |
Tribe (Alan William) |
Former | 0 | Other |
Fundamentals
Market cap$2.04B
Enterprise value$1.09B
Revenue (TTM)$20.56M
Gross profit$20.56M
EBITDA$-51.41M
Net income$-47.56M
EPS (TTM)$-0.08
Free cash flow$-51.59M
Total cash$120.69M
Total debt$827.08K
Book value / share$0.25
Shares outstanding983.51M
Float373.18M
Short % of float—
Dividend yield—
Beta (5Y)1.05
Valuation & profitability ratios
Trailing P/E—
Forward P/E-22.45
PEG ratio—
Price / sales—
Price / book8.21
EV / revenue52.90
EV / EBITDA-21.16
Gross margin100.00%
Operating margin-283.46%
Profit margin-231.33%
Return on equity-47.55%
Return on assets-28.68%
Debt / equity0.56
Current ratio13.96
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Research & development | $70.05M | $56.41M | $35.15M | $24.03M | +24.2% |
| Selling, general & admin | $4.21M | $2.40M | $2.54M | $4.38M | +75.1% |
| Total operating expense | $75.92M | $60.42M | $39.16M | $30.21M | +25.6% |
| Operating income | -$75.92M | -$60.42M | -$39.16M | -$30.21M | -25.6% |
| Net interest income | $2.61M | $746.77K | $54.56K | -$8.17K | +250.1% |
| Pre-tax income | -$51.01M | -$38.11M | -$23.36M | -$14.29M | -33.9% |
| Tax provision | $0 | $0 | $0 | $0 | — |
| Net income | -$50.30M | -$37.73M | -$22.79M | -$13.86M | -33.3% |
| Net income to common | -$50.30M | -$37.73M | -$22.79M | -$13.86M | -33.3% |
| Basic EPS | -0.10 | -0.09 | -0.07 | -0.04 | -5.3% |
| Diluted EPS | -0.10 | -0.09 | -0.07 | -0.04 | -5.3% |
| EBIT | -$50.95M | -$38.06M | -$23.33M | -$14.26M | -33.9% |
| EBITDA | -$50.35M | -$37.46M | -$22.78M | -$13.42M | -34.4% |
| Basic shares | 512.52M | 405.24M | 334.50M | 331.41M | +26.5% |
| Diluted shares | 512.52M | 405.24M | 334.50M | 331.41M | +26.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $153.05M | $66.87M | $15.57M | $29.11M | +128.9% |
| Cash & short-term investments | $153.05M | $66.87M | $15.57M | $29.11M | +128.9% |
| Total current assets | $177.53M | $85.61M | $31.87M | $39.25M | +107.4% |
| Property, plant & equipment | $1.90M | $1.57M | $1.04M | $1.63M | +20.9% |
| Goodwill & intangibles | $3.85M | $4.05M | $4.25M | $4.45M | -4.9% |
| Total assets | $183.28M | $91.24M | $37.17M | $45.35M | +100.9% |
| Total current liabilities | $12.32M | $9.11M | $8.41M | $4.39M | +35.2% |
| Total debt | $1.02M | $1.11M | $315.49K | $943.77K | -8.0% |
| Total liabilities | $13.27M | $10.18M | $8.72M | $5.15M | +30.3% |
| Retained earnings | -$206.20M | -$155.89M | -$118.17M | -$95.38M | -32.3% |
| Shareholder equity | $169.57M | $80.50M | $27.75M | $39.35M | +110.7% |
| Working capital | $165.21M | $76.51M | $23.47M | $34.86M | +115.9% |
| Net tangible assets | $165.72M | $76.45M | $23.50M | $34.90M | +116.8% |
| Shares issued | 597.26M | 480.42M | 355.95M | 331.41M | +24.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Capital expenditure | -$975.40K | -$307.04K | -$491.12K | -$386.91K | -217.7% |
| Investing cash flow | -$975.40K | -$307.04K | -$477.12K | $32.68M | -217.7% |
| Share buybacks | -$6.80M | -$1.57M | -$976.25K | — | -333.6% |
| Financing cash flow | $138.66M | $90.19M | $11.44M | -$182.36K | +53.7% |
| Free cash flow | -$52.54M | -$38.90M | -$24.91M | -$22.17M | -35.1% |
| End cash position | $153.05M | $66.87M | $15.57M | $29.11M | +128.9% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-06-30 | YoY |
|---|---|---|
| Cash & equivalents | $153.05M | |
| Cash & short-term investments | $153.05M | |
| Total current assets | $177.53M | |
| Property, plant & equipment | $1.90M | |
| Goodwill & intangibles | $3.85M | |
| Total assets | $183.28M | |
| Total current liabilities | $12.32M | |
| Total debt | $1.02M | |
| Total liabilities | $13.27M | |
| Retained earnings | -$206.20M | |
| Shareholder equity | $169.57M | |
| Working capital | $165.21M | |
| Net tangible assets | $165.72M | |
| Shares issued | 597.26M |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | -0.07 | 5 | $3.67M | -86.0% |
| Next year | -0.09 | 5 | $0 | -100.0% |
Analyst targets & ownership
Mean target$3.75
High target$5.00
Low target$2.30
Implied upside81.26%
Analyst count5
ConsensusSTRONG BUY
Strong buy / Buy1 / 5
Hold0
Sell / Strong sell0 / 0
Held by insiders32.97%
Held by institutions16.44%
Institutions holding23
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
2.14
-3.27% from price
SMA 20
1.99
+4.01% from price
SMA 50
1.73
+19.90% from price
SMA 100
1.50
+38.42% from price
SMA 200
1.49
+39.18% from price
EMA 12
2.09
-0.81% from price
EMA 26
1.95
+6.13% from price
EMA 50
1.79
+15.89% from price
RSI (14)
60.0
Neutral
MACD (12,26,9)
0.14
Hist -0.01
ATR (14)
0.11
5.52% of price
Realised vol 30D
53.4%
Annualised
Bollinger upper
2.40
20, 2σ
Bollinger lower
1.58
20, 2σ
50 / 200 cross
Golden
1.73 vs 1.49
Trend bias
Above 200
+39.18%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.55
Less volatile than market
Correlation to SPY
0.12
Largely independent
Realised vol 30D
53.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-38.8%
Peak to trough
Max drawdown 5Y
-66.5%
Peak to trough
ATR 14
0.11
5.52% of price
Beta (reported)
1.05
5Y monthly, from filing
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:10
Split dateNov 15, 2024
Headlines
Thousands expected at Sweden climate demo as election looms
AFP · 11m ago
Cowboys vs. Cardinals highlights Preseason Week 2
NFL Highlights · 15m ago
Which Energy ETF Is a Better Buy: Broad Vanguard Fund or Concentrated XLE?
Motley Fool · 17m ago
Joe Milton III's best plays from 3-TD game vs. Cardinals Preseason Week 2
NFL Highlights · 26m ago
BioNTech (BNTX) Is Up 25.2% After First-in-Class Pumitamig Plus B7H3 ADC Lung Data – What's Changed
Simply Wall St. · 31m ago
Applied Industrial Technologies (AIT) Could Be 15% Undervalued After Earnings And 2027 Guidance
Simply Wall St. · 31m ago
Everpure (P) Lands Supply Agreement With A Second Top Five Hyperscaler
Simply Wall St. · 31m ago
Is Red Cat Holdings (RCAT) Quietly Recasting Its Identity From Drone Maker To Full Autonomy Platform?
Simply Wall St. · 32m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.